Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.8 - $1.12 $298 - $417
-373 Reduced 98.68%
5 $0
Q3 2022

Nov 14, 2022

SELL
$0.91 - $1.69 $750 - $1,394
-825 Reduced 68.58%
378 $0
Q2 2022

Aug 12, 2022

SELL
$1.28 - $2.4 $1,022 - $1,917
-799 Reduced 39.91%
1,203 $2,000
Q1 2022

May 16, 2022

SELL
$2.19 - $6.09 $498,222 - $1.39 Million
-227,499 Reduced 99.13%
2,002 $4,000
Q4 2021

Feb 08, 2022

BUY
$5.81 - $14.39 $31,984 - $79,216
5,505 Added 2.46%
229,501 $1.4 Million
Q3 2021

Nov 15, 2021

SELL
$11.55 - $20.3 $88,334 - $155,254
-7,648 Reduced 3.3%
223,996 $3.1 Million
Q2 2021

Sep 13, 2021

BUY
$17.9 - $23.29 $4.15 Million - $5.39 Million
231,644 New
231,644 $4.66 Million

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.